Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Evogene logo — Real-World Innovation. Pioneering chemical Discovery with Ge...

Evogene

Real-World Innovation. Pioneering chemical Discovery with Generative AI

Founded 2002 Israel Israel 99 employees IPO Total: $28.30M Agriculture, Biotechnology +1

General Information

Company Name Evogene
Founded Year 2002
Location Israel Israel
Employees 99
Industries Agriculture, Biotechnology, AgriTech
Funding Stage IPO
Business Model B2B, Platform, B2B2B
Revenue Model Licensing, Project Based, Performance Based
Social

BounceWatch is an independent company data service, not affiliated with Evogene. To contact Evogene, visit evogene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Evogene compare?

A PDF of Evogene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Evogene soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 27, 2026

Evogene will present a scientific poster at Drug Discovery Chemistry Europe 2026 in Barcelona, Spain.

Evogene a competitor of yours? Have our desk watch it

About Evogene

Evogene Ltd. (Nasdaq/TASE: EVGN) is a trailblazer in the realm of computational chemistry, leveraging its expertise to design small molecules for the pharmaceutical and agricultural sectors. Founded in 2002 and headquartered in Israel, the company operates at the intersection of Agriculture and Biotechnology industries.

At the heart of Evogene's technological prowess lies ChemPass AI, a groundbreaking generative AI engine. This proprietary platform excels at crafting novel, potent small molecules, optimizing them across vital parameters to bolster success rates while slashing development time and costs.

In a strategic move, Evogene recently secured an $8.50M Post-IPO equity investment on July 17, 2023, backed by prominent investors including Altium Capital, Silverarc Capital, and CVI Investments. This strategic funding underscores the company's commitment to integrating scientific innovation with tangible industry applications, embracing what they term as "Real-World Innovation."

Business keywords: Computational Chemistry, Generative AI, Small Molecule Design, Pharmaceutical Industry, Agricultural Industry, ChemPass AI, Ag-Biotech, Trait Development, Plant Genomics, Seed Traits, Breeding Methods, Crop Performance, Drug Discovery, Life-Science Innovation

Services & Products

Generative AI for Molecule Design
AI-Driven Drug Discovery
Next-Generation Crop Protection
Collaborative Innovation with Partners

Target Customers

Pharmaceutical Companies Agriculture Industry Biotech Researchers Healthcare Innovators

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity $8.50M -
01 May 2026
Post-IPO Equity $3.40M -
01 Feb 2026
Private Placement Non VC $5.50M -
01 Aug 2024
Post-IPO Equity $10.00M 1
Ark Invest
Ark Invest
01 Sep 2020
Grant €900.00K 1
Horizon 2020 FET (Future and Emerging Technologies)
01 Aug 2015
IPO Undisclosed -
01 May 2008

Evogene Alternatives & Competitors

View All Alternatives
Evogene vs
GOENOMICS GmbH
GOENOMICS GmbH Germany

World of biological sequences

Non Equity Assistance
4 employees
AI, Big Data
Compare Evogene vs GOENOMICS GmbH
Evogene vs
Solynta | true potato seeds
Solynta | true potato seeds The Netherlands

Unlocking the True Potential of Potatoes

Series C
94 employees
Agriculture, Biotechnology
Compare Evogene vs Solynta | true potato seeds
Evogene vs
Starfield Crop Science
Starfield Crop Science India

Breeding research of various crops to develop and market hybrid and open-pollinated seeds.

2 employees
Agriculture, Biotechnology
Compare Evogene vs Starfield Crop Science
View all alternatives

FAQ About Evogene

Real-World Innovation. Pioneering chemical Discovery with Generative AI
Evogene was founded in 2002.
Evogene is headquartered in Israel.
Evogene operates in Agriculture, Biotechnology and AgriTech. Its work centres on Computational Chemistry, Generative AI, Small Molecule Design and Pharmaceutical Industry. Its customers include Pharmaceutical Companies, Agriculture Industry and Biotech Researchers.
Evogene has a B2B, Platform and B2B2B business model. Its revenue comes from Licensing, Project Based and Performance Based.
Evogene has approximately 99 employees.
Evogene has completed 6 funding rounds, raising a total of $28.30M. The latest funding stage is IPO.
Evogene offers: Generative AI for Molecule Design, AI-Driven Drug Discovery, Next-Generation Crop Protection, Collaborative Innovation with Partners.
Top alternatives and competitors to Evogene include GOENOMICS GmbH, Solynta | true potato seeds, Starfield Crop Science, Green World Genetics Sdn Bhd, GreenLight Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Evogene and GOENOMICS GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Evogene, https://www.bouncewatch.com/company/evogene, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout